Lindsey Rolfe
2017
In 2017, Lindsey Rolfe earned a total compensation of $2.4M as EVP of Clinical and Development and Pharmacovigilance and Chief Medical Officer at Clovis Oncology, a 18% decrease compared to previous year.
Compensation breakdown
| Bonus | $243,225 |
|---|---|
| Option Awards | $1,011,688 |
| Salary | $463,838 |
| Stock Awards | $683,100 |
| Other | $27,830 |
| Total | $2,429,681 |
Rolfe received $1M in option awards, accounting for 42% of the total pay in 2017.
Rolfe also received $243.2K in bonus, $463.8K in salary, $683.1K in stock awards and $27.8K in other compensation.
Rankings
In 2017, Lindsey Rolfe's compensation ranked 4,571st out of 14,666 executives tracked by ExecPay. In other words, Rolfe earned more than 68.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,571 out of 14,666 | 69th |
Division Manufacturing | 1,612 out of 5,768 | 72nd |
Major group Chemicals And Allied Products | 466 out of 2,074 | 78th |
Industry group Drugs | 359 out of 1,730 | 79th |
Industry Pharmaceutical Preparations | 286 out of 1,329 | 79th |
Source: SEC filing on April 27, 2018.
Rolfe's colleagues
We found four more compensation records of executives who worked with Lindsey Rolfe at Clovis Oncology in 2017.
2017
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
2017
Gillian Ivers-Read
Clovis Oncology
EVP of Technical Operations and Chief Regulatory Officer
2017
C Hooks
Clovis Oncology
Senior VP and Chief Commercial Officer
2017
Daniel Muehl
Clovis Oncology
Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019